Board

Board of the GDCh Division of Medicinal Chemistry

2023-2026

Dr. Gerhard Heßler (Chair), Sanofi-Aventis Germany, Frankfurt aM

Dr. Tatjana Ross (Deputy Chair), Merck KGaA, Darmstadt

Prof. Dr. Christian Ducho, Saarland University, Saarbrücken

Prof. Dr. Anna Hirsch, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken

Dr. Christian Kuttruff, Boehringer-Ingelheim International GmbH, Biberach

Prof. Dr. Holger Stark, Heinrich Heine University Düsseldorf


Permanent guest of the board
Prof. Dr. Matthias Gehringer, Eberhard Karls University of Tübingen ( NextGenMedChem representative )

2019-2022

v.l.n.r.: H. Dollinger, G. Heßler, A. Hirsch,
S. Laufer, C. Ducho, F. von Nussbaum
(Quelle: F. von Nussbaum)

Dr. Franz von Nussbaum (Chair), Nuvisan ICB GmbH, Berlin
Prof. Dr. Anna Hirsch (Deputy Chair), Helmholtz Institute for Pharmaceutical Research (HIPS), Saarbrücken
Dr. Horst Dollinger, Schemmerhofen
Prof. Dr. Christian Ducho, Saarland University, Saarbrücken
Dr. Gerhard Heßler, Sanofi-Aventis Deutschland GmbH, Frankfurt aM
Prof. Dr. Stefan Laufer, University of Tübingen

This page has been machine translated. If you have any feedback or comments please feel free to contact us.

last modified: 26.05.2025 18:29 H from Translator